Patent · US Active

Bispecific, tetravalent antigen binding proteins

US8703132B2 · kind B2 · utility

37Cited by

2References

11Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Sabine Imhof-Jung · Planegg, DE
Christian Klein · Iffeldorf, DE
Joerg Thomas Regula · Munich, DE
Wolfgang Schaefer · Sankt Augustin, DE
Juergen Michael Schanzer · Traunstein, DE

Key dates

Filing date	May 25, 2010
Grant date	Apr 22, 2014
Priority date	—
Expiry date	Dec 25, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/00
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention relates to bispecific, tetravalent antigen binding proteins, methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.